McNeill Jonathan

CIK 00018246732 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001824673

Recent Transactions

50 trades

Award
CRESCENT BIOPHARMA, INC.$CBIO
Ordinary Shares
2025-12-15+6,000→ 159,707 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (Right to Buy)
2025-12-15+78,029→ 78,029 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Ordinary Shares
2025-12-15+19,507→ 153,707 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Stock Option (Right to Buy)
2025-12-08+172,836→ 172,836 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$45.01/sh−2,400→ 132,411 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-08-19$46.00/sh−305→ 132,106 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-06-11$31.34/sh−1,823→ 134,811 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.59/sh−495→ 136,634 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-05-16$28.20/sh−2,279→ 137,129 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-11$5.54/sh+17,825→ 159,009 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-11$25.71/sh−1,776→ 139,408 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-03-11−17,825→ 0 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-11$25.48/sh−17,825→ 141,184 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$27.31/sh−689→ 141,184 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-03-08−3,841
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-03-08−86,159→ 12,309 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$5.54/sh+86,159→ 227,343 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$5.54/sh+3,841→ 231,184 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$26.72/sh−54,648→ 141,873 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-08$25.46/sh−34,663→ 196,521 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-07$25.85/sh−2,434→ 141,184 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-03-01−24,260→ 0 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$0.73/sh+24,260→ 167,878 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$28.25/sh−14,103→ 153,775 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$29.06/sh−8,715→ 145,060 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-03-01$29.70/sh−1,442→ 143,618 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-29$0.73/sh+4,268→ 147,886 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-02-29$27.50/sh−4,268→ 143,618 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-02-29−4,268→ 24,260 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-26$25.14/sh−178→ 143,618 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-26$0.73/sh+20,000→ 163,618 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-01-26−20,000→ 28,528 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-26$24.52/sh−19,822→ 143,796 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-01-04−2,009→ 48,528 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-04$18.04/sh−2,009→ 143,618 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-04$0.73/sh+2,009→ 145,627 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-03$19.03/sh−10,300→ 143,618 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-03$18.34/sh−7,691→ 153,918 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-03$0.73/sh+17,991→ 161,609 total
Exercise/Conversion
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2024-01-03−17,991→ 50,537 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2024-01-02$13.10/sh−11,900→ 143,618 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-12-11$10.72/sh−1,245→ 155,518 total
Award
Dyne Therapeutics, Inc.$DYN
Stock Option (right to buy)
2023-11-15+37,445→ 37,445 total
Award
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-11-15+96,158→ 156,763 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-09-18$9.41/sh−1,261→ 60,605 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-09-12$10.41/sh−1,266→ 61,866 total
Award
Dyne Therapeutics, Inc.$DYN
Stock option (right to buy)
2023-07-11+35,000→ 35,000 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-06-13$12.43/sh−1,259→ 63,132 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-06-12$13.00/sh−1,000→ 64,391 total
Sale
Dyne Therapeutics, Inc.$DYN
Common Stock
2023-03-14$13.33/sh−1,209→ 65,391 total

Companies

Recent Filings

Address

C/O CRESCENT BIOPHARMA, INC. 300 FIFTH AVENUE

WALTHAM, MA, 02451

View on SEC.gov